Astera Labs (NASDAQ:ALAB) Shares Down 8.2% – Time to Sell?

Astera Labs, Inc. (NASDAQ:ALAB) shares traded down 8.2% during trading on Wednesday . The company traded as low as $331.28 and last traded at $331.87. Approximately 2,354,870 shares were traded during trading, a decline of 57% from the average session volume of 5,537,341 shares. The stock had previously closed at $361.67.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q2 results significantly exceeded expectations: Revenue reached a record $392.4 million, up 104.5% year over year and 27% sequentially, while earnings per share of $0.80 surpassed the $0.69 consensus estimate. Astera Labs Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Q3 outlook was far above analyst forecasts: Astera Labs guided for revenue of $540 million to $560 million and EPS of $1.16 to $1.21, compared with consensus estimates of $410.3 million and $0.73, respectively. The outlook implies roughly 40% sequential revenue growth. Astera Labs Sees Revenue Jumping 40% Next Quarter
• Positive Sentiment: Scorpio X-Series momentum is accelerating: The 320-lane fabric switch entered volume production one quarter ahead of schedule and is expected to be a major Q3 growth driver. PCIe 6 products now account for more than half of revenue, reflecting strong AI infrastructure demand. ALAB Q2 Earnings Call Puts Scorpio Ramp Ahead of Schedule
• Positive Sentiment: Analyst sentiment improved: Needham raised its price target to $425 and maintained a Buy rating, while other analysts increased forecasts following the earnings report. Needham Raises Astera Labs Price Target
• Negative Sentiment: Valuation and expectations remain concerns: With the stock trading at a very high earnings multiple after a substantial run-up, one analyst downgraded the shares, arguing that the “easy money” phase is over. Investors may be taking profits despite the strong fundamentals and demanding guidance. Astera Labs Rating Downgrade

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Stifel Nicolaus increased their target price on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Royal Bank Of Canada boosted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday. Jefferies Financial Group upped their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Citigroup reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $327.75.

Astera Labs Stock Down 11.0%

The stock has a market cap of $55.15 billion, a P/E ratio of 216.46, a price-to-earnings-growth ratio of 3.72 and a beta of 3.84. The firm’s 50-day moving average is $361.12 and its two-hundred day moving average is $232.51.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $1,577,250.00. Following the transaction, the director owned 57,466 shares in the company, valued at approximately $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,676,845 shares of company stock valued at $444,928,806 in the last three months. 10.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ALAB. Reflection Asset Management bought a new position in shares of Astera Labs in the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC boosted its position in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs during the fourth quarter valued at approximately $33,000. Whipplewood Advisors LLC grew its holdings in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the last quarter. Finally, Assetmark Inc. grew its holdings in Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after purchasing an additional 101 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.